BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luger T, Paller AS, Irvine AD, Sidbury R, Eichenfield LF, Werfel T, Bieber T. Topical therapy of atopic dermatitis with a focus on pimecrolimus. J Eur Acad Dermatol Venereol 2021;35:1505-18. [PMID: 33834524 DOI: 10.1111/jdv.17272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wairkar S, Patel D, Singh A. Nanostructured lipid carrier based dermal gel of cyclosporine for atopic dermatitis-in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology 2022;72:103365. [DOI: 10.1016/j.jddst.2022.103365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Appiah MM, Haft MA, Kleinman E, Laborada J, Lee S, Loop L, Geng B, Eichenfield LF. Atopic dermatitis. Ann Allergy Asthma Immunol 2022:S1081-1206(22)00446-X. [PMID: 35609746 DOI: 10.1016/j.anai.2022.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Freimooser S, Traidl S, Werfel T. Entwicklung von neuen topischen Substanzen zur Therapie der atopischen Dermatitis. Hautarzt. [DOI: 10.1007/s00105-022-05005-5] [Reference Citation Analysis]
4 Hrestak D, Matijašić M, Čipčić Paljetak H, Ledić Drvar D, Ljubojević Hadžavdić S, Perić M. Skin Microbiota in Atopic Dermatitis. Int J Mol Sci 2022;23:3503. [PMID: 35408862 DOI: 10.3390/ijms23073503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wong LS, Yen YT, Lee CH. The Implications of Pruritogens in the Pathogenesis of Atopic Dermatitis. Int J Mol Sci 2021;22:7227. [PMID: 34281281 DOI: 10.3390/ijms22137227] [Cited by in F6Publishing: 4] [Reference Citation Analysis]